US NEUROLOGY – VOLUME 13 ISSUE 2 – FALL 2017

Welcome to the fall edition of US Neurology. This issue features a number of topical articles that have been chosen for their evaluation of current practices and research that directly affect neurologists and other practitioners involved in the care of patients with neurological illness. We begin with an editorial on the subject of Alzheimer’s disease […]

New guidelines from the American Academy of Neurology (AAN) and the American Epilepsy Society on sudden unexpected death in epilepsy (SUDEP) were presented at the 69th Annual AAN Meeting held in Boston, MA, US, May 28–22, 2017 in parallel with their publication in Neurology.1 In an expert interview, Dr Cynthia L Harden of Mount Sinai […]

Alzheimer’s disease (AD) is approaching epidemic proportions as the world’s population ages and the number of victims of this age-related disorder soars.1 At the same time that this tsunami of affected individuals looms, there has been little progress in developing new therapies, either symptomatic drugs to relieve the symptoms of AD or disease-modifying therapies (DMTs) […]

The importance of exercise for symptom management in multiple sclerosis (MS) has gained increasing momentum over the last 25 years. It was not so long ago that patients with MS were advised to avoid exercise. Studies in the 1970s showed evidence suggesting that increasing body temperature when exercising caused variable changes in motor function for […]

In April 2017, the International League Against Epilepsy (ILAE), which is the parent body of over 100 national professional epilepsy societies, published a revised operational classification of seizure types1–4 and epilepsies.5 The seizure classification was a revision of the classification established in 19816 and partially updated in 2010.7 The 1981 classification, which included the terms […]

Identifying secondary headaches in the emergency room In 2008 alone (according to most recent data), there were over 3 million visits to the emergency room (ER) where headache was the primary complaint, in the US.1 Headache comprised a little over 2% of all ER visits, making it one of the most common neurological complaints in […]